glp 1 new GLP-1 analogs, trend in obesity treatment, become even more effective < Pharma < Article GLP-1 Medications for Weight Loss

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.

Deal would mark the logistics companys return to public markets Read more at The Business Times.

Physicians may prescribe compounded medications as needed to meet patient requirements or address drug shortages

We further explore the potential actions of multi-agonist drugs as well as the mechanisms through which gut-brain communication can be used to achieve long-term weight loss without negative side effects

However, PKA inhibition but not GLP-1R blockade eliminated the protective effects of metformin on endothelial function